Our news library that includes all press releases and industry related news.
Press Release July 06, 2022
Ottawa, July 6, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, acknowledges the amendments to […]
Press Release June 17, 2022
Ottawa, June 17, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, is disappointed by the intellectual […]
Press Release June 15, 2022
Ottawa, June 15, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, acknowledges the release of the […]
Press Release June 10, 2022
Ottawa, June 9, 2022 – The associations representing the global research-based biopharmaceutical industry reaffirm that weakening the intellectual property (IP) framework […]
Press Release June 06, 2022
Ottawa, June 6, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, applauds the Quebec government on […]
Press Release May 30, 2022
Ottawa, May 30, 2022 – Innovative Medicines Canada (IMC) is pleased to announce Alok Kanti, President and Chief Executive Officer of […]
Press Release May 25, 2022
Nominate a remarkable individual who is making a difference in health sciences by June 22. OTTAWA, ON, May 25, 2022 […]
Press Release May 12, 2022
Ottawa, May 12, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, welcomes Quebec’s new Life […]
Press Release April 28, 2022
Ottawa, April 28, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement in response to […]
Press Release April 20, 2022
Ottawa, April 20, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement […]
Press Release April 08, 2022
IMC is pleased with the ongoing commitments to increased access to innovative medicines and treatments […]
Press Release March 31, 2022
Ottawa, March 31, 2022 – Innovative Medicines Canada (IMC) is disappointed by the latest Patented Medicine Prices Review Board (PMPRB) […]
Informative content to keep you up to date on the most pressing issues facing our industry.
